Medicare Enrolled

Dr. Gregory Van Dyke, MD, PHD

Dermatopathology (Pathology) Physician · Studio City, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
12409 VENTURA CT, Studio City, CA 91604
8189006007
In practice since 2007 (19 years)
NPI: 1841328614 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Van Dyke from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Van Dyke? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Van Dyke

Dr. Gregory Van Dyke is a dermatopathology physician in Studio City, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Van Dyke performed 11,383 Medicare services across 7,143 unique beneficiaries.

Between the years covered by Open Payments, Dr. Van Dyke received a total of $7,088 from 40 pharmaceutical and/or device companies across 349 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatopathology (pathology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Van Dyke is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 11% volume in CA $7,088 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,383
Medicare services
Top 11% in CA for dermatopathology (pathology) physician
7,143
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~599 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
6,189 $36 $97
Surgical pathology consultation on referred slides
A pathologist reviews and reports on tissue slides that were prepared at another facility. This service provides a second opinion or expert analysis of the existing samples.
3,972 $79 $226
Surgical pathology consultation with slide preparation
A specialist reviews tissue samples sent by another provider, preparing necessary slides for examination. The specialist then provides a diagnostic report based on this analysis.
636 $71 $198
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
100 $6 $16
Tissue staining for diagnosis, additional
An extra laboratory procedure to apply special stains to tissue slides for detailed examination.
76 $77 $201
Special stain test for organisms
A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results.
71 $98 $225
Tissue staining for diagnosis, initial
A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics.
63 $90 $241
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
60 $45 $126
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
53 $41 $154
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
48 $67 $200
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
30 $85 $265
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
28 $73 $236
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
21 $82 $247
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
20 $50 $162
Special tissue stain and interpretation
A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings.
16 $76 $159
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,088
Total received (2018-2024)
Avg $1,013/year across 7 years
Top 5% in CA for dermatopathology (pathology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
349
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,088 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,095
2023
$1,489
2022
$1,265
2021
$954
2020
$659
2019
$465
2018
$162

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$515
Regeneron Healthcare Solutions, Inc.
$208
UCB, Inc.
$207
REVANCE THERAPEUTICS, INC.
$198
Ortho Dermatologics, a division of Bausch Health US, LLC
$168
LEO Pharma Inc.
$117
Incyte Corporation
$116
GENZYME CORPORATION
$114
Janssen Biotech, Inc.
$101
Amgen Inc.
$57
Lilly USA, LLC
$50
MAYNE PHARMA COMMERCIAL LLC
$46
Arcutis Biotherapeutics, Inc.
$35
SUN PHARMACEUTICAL INDUSTRIES INC.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Dermavant Sciences, Inc.
$30
Journey Medical Corporation
$23
Galderma Laboratories, L.P.
$22
Sandoz Inc.
$22
Top 3 companies account for 44.4% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$987
UCB, Inc.
$832
ABBVIE INC.
$759
Regeneron Healthcare Solutions, Inc.
$511
Amgen Inc.
$373
GENZYME CORPORATION
$348
Galderma Laboratories, L.P.
$276
Sun Pharmaceutical Industries Inc.
$271
Janssen Biotech, Inc.
$265
LEO Pharma Inc.
$264
Ortho Dermatologics, a division of Bausch Health US, LLC
$217
Incyte Corporation
$201
REVANCE THERAPEUTICS, INC.
$198
Lilly USA, LLC
$167
MAYNE PHARMA INC.
$163
Genentech USA, Inc.
$145
SUN PHARMACEUTICAL INDUSTRIES INC.
$142
Almirall LLC
$107
Dermavant Sciences, Inc.
$79
Novartis Pharmaceuticals Corporation
$74
AbbVie, Inc.
$72
PFIZER INC.
$71
Mayne Pharma Inc.
$71
Bayer HealthCare Pharmaceuticals Inc.
$69
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
MAYNE PHARMA COMMERCIAL LLC
$46
Solta Medical, a division of Bausch Health US, LLC
$40
Arcutis Biotherapeutics, Inc.
$35
E.R. Squibb & Sons, L.L.C.
$29
Helsinn Therapeutics (U.S.), Inc.
$28
Celgene Corporation
$23
Journey Medical Corporation
$23
DUSA Pharmaceuticals, Inc.
$22
Sandoz Inc.
$22
Allergan, Inc.
$21
Biofrontera Inc.
$20
Medimetriks Pharmaceuticals, Inc.
$19
VYNE Pharmaceuticals Inc.
$18
Merz North America, Inc.
$17
EPI Health, LLC
$14
Top 3 companies account for 36.4% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA LD · ADBRY · AKLIEF · AMZEEQ · Absorica LD · Ameluz · BLU-U · BOTOX · BRYHALI · Bimzelx · COSENTYX · Cabtreo · Cimzia · Clear & Brilliant · DAXXIFY · DORYX · DUPIXENT · ENSTILAR · EPIDUO FORTE · EUCRISA · Erivedge · FINACEA · Finacea · HUMIRA · HYRIMOZ · Humira · ILUMYA · Ilumya · JUBLIA · LIBTAYO · OPZELURA · ORACEA · Otezla · REMICADE · RINVOQ · SILIQ · SKYRIZI · SPEVIGO · Seysara · Sitavig · Skyrizi · TALTZ · TREMFYA · VALCHLOR · VTAMA · Veltin · Winlevi · XEOMIN · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for dermatopathology (pathology) physician in CA.

Looking for a dermatopathology physician in Studio City?
Compare dermatopathology physicians in the Studio City area by procedure volume, costs, and industry payment transparency.
Browse dermatopathology physicians nearby

Geographic Context

Dermatopathology physicians within 10 mi
20
Per 100K population
0.2
County median income
$87,760
Nearest hospital
PROVIDENCE SAINT JOSEPH MEDICAL CTR
3.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Van Dyke is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement in the top 5% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Van Dyke experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Van Dyke performed 6,189 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Van Dyke receive payments from pharmaceutical companies?
Yes. Dr. Van Dyke received a total of $7,088 from 40 companies across 349 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Van Dyke's costs compare to other dermatopathology physicians in Studio City?
Dr. Van Dyke's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Van Dyke) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →